1 | Recommendations should specify how to consider age, multimorbidity, risk of progression, life expectancy, health goals and quality of life. |
2 | Recommendations on referral should distinguish between interdisciplinary or co-treatment and one-time consultations for specific problems or to rule out specific kidney diseases. |
3 | Guidelines should be comprehensive and include management recommendations for common CKD-related problems usually solved in primary care. |
4 | All relevant options including the option of abstaining from diagnosis or therapy should be incorporated in the guideline. |
5 | Increase involvement of stakeholders and target users, particularly non-nephrologists in the development process. |
6 | Implications for cost and resources in the healthcare system should be considered when formulating recommendations. |
7 | Facilitators and barriers to implementation and adoption of the guideline in clinical practice should be identified and analyzed and the results should be incorporated during the guideline development process. |
8 | A procedure and timeframe for updating the guideline should be specified. |